Bepranemab is an anti-tau reference monoclonal antibody used in research on neurodegenerative diseases, such as Alzheimer’s disease. It helps detect misfolded tau protein in the brain, which is associated with neuronal degeneration. Commonly used in techniques like Western blot, immunohistochemistry, and ELISA to measure the levels and localization of tau protein in tissue samples or biological fluids. It supports drug development and early disease diagnosis.